MENU

Admission to drug treatment and rehabilitation centers to resume with strict health and safety protocols amid the pandemic

Adjusting to the “New Normal,” the Dangerous Drugs Board (DDB) adopted infection prevention and control protocol to be followed upon the resumption of admissions and activities in drug treatment and rehabilitation facilities nationwide.

Read more ...

DDB issues policy to ensure availability of physicians authorized to assess substance use disorder amid the pandemic

The Dangerous Drugs Board, in its recent special meeting, approved a Resolution extending the validity of provisional accreditation granted to physicians authorized to conduct Drug Dependency Examination (DDE) for a period of two years.

Read more ...

DDB refutes heavy-handed approach in UN-OHCHR drug war report

The Philippine Government takes exception to the Office of the United Nations High Commissioner for Human Rights (OHCHR) Report, especially as it relates to Philippine efforts to effectively address the pervasive menace and destructive effects of illegal drugs in the country.

The Philippines calls on the OHCHR to foster a positive spirit of cooperation with States Parties, with the view of releasing an unbiased report based on facts, legitimate figures and continuing consultations with key anti-drug agencies in the Philippines.

Read more ...

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

 

REPORTED CASES BY TYPE OF ADMISSION AND SEX
(Facility Based)*
CY 2017
 
TYPE OF ADMISSION MALE FEMALE GRAND TOTAL
No. % No.  % No. %
NEW ADMISSION 2,951 72.95 305 7.54 3,256 80.49
RE-ADMISSION 581 14.36 52 1.29 633 15.65
OUT-PATIENT 149 3.68 7 0.17 156 3.86
TOTAL 3,681 91.00 364 9.00 4,045 100.00

* Total Reported Cases from Residential and Out-Patient Facilities

 

PROFILE OF DRUG ABUSERS
(Facility Based)*
CY 2017

• AGE : Mean age of 31 years
• SEX : Ratio of male and female 10:1
• CIVIL STATUS : Single 53.52%
• STATUS OF EMPLOYMENT : Unemployed 45.96%
• EDUCATIONAL ATTAINMENT : High School Level 27.32%
• ECONOMIC STATUS : Average Monthly Family Income Php 12,337.57
• PLACE OF RESIDENCE : Urban (Specifically NCR 43.31%)
• DURATION OF DRUG USE : More than 6 years
• NATURE OF DRUG TAKING : Mono drug use**
• DRUGS/SUBSTANCES OF ABUSE :
Methamphetamine Hydrochloride (Shabu)
Cannabis (Marijuana)
Contact Cement (Rugby)
*Residential and Out-Patient Facilities
**Mono drug users - abuse of one (1) drug only